Expression of A1 and A3 adenosine receptors in human breast tumors

Area of Science:

• Molecular Biology
• Oncology
• Pharmacology

Background:

• Adenosine receptors (A1, A2A, A2B, A3) are crucial in regulating cell growth, proliferation, and death in both normal and cancerous cells.
• Previous research established the expression profiles of A2A and A2B receptors in breast tissues.
• This study focuses on the expression of A1 and A3 adenosine receptors in normal and tumor breast tissues.

Purpose of the Study:

• To quantify the gene expression levels of A1 and A3 adenosine receptors in normal and tumor breast tissues.
• To investigate the differential expression of A1 and A3 adenosine receptors between non-neoplastic and neoplastic mammary tissues.

Main Methods:

• Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was employed to measure A1 and A3 adenosine receptor gene expression.
• Total RNA was extracted from 18 breast tumors and 10 non-neoplastic mammary tissues.
• Beta-actin mRNA served as an internal control for normalization, with PCR product band intensities quantified using ImageJ software.

Main Results:

• Both A1 and A3 adenosine receptor transcripts were detected in all analyzed breast tumor and normal tissue specimens.
• A significant 1.27-fold increase in A3 adenosine receptor expression was observed in tumor tissues compared to normal tissues.
• No significant difference in A1 adenosine receptor expression levels was found between normal and tumor breast tissues.

Conclusions:

• The elevated expression of A3 adenosine receptor transcripts in breast tumors suggests a potential role in tumor development.
• These findings support the hypothesis that the A3 adenosine receptor may be a key player in breast cancer progression.
• Further research utilizing real-time quantitative RT-PCR is recommended to precisely determine gene expression levels and validate these findings.